Enter your email address
Submit
Write your message
International Journal of Molecular and Cellular Medicine (IJMCM)
Cellular and Molecular Biology Research Center, Babol University of Medical Sciences
Sat, Dec 21, 2024
[Archive]
Welcome
International Journal of Molecular and Cellular Medicine (IJMCM)
Open Access
Int J Mol Cell Med, Volume 11, No 4, Serial: 44 (Autumn 2022)
p-ISSN: 2251-9637 e-ISSN: 2251-9645
To cover the cost of publication, authors will pay an Article Processing Charge (APC) for accepted manuscripts from January 1, 2025.
Indexed in: Web of Sciences (ISI), PubMed, Scopus, Google Scholar, CAS, Index Copernicus, Index Medicus (IMEMR), ESJI, ISC, SID, Magiran, and Iranmedex
Impact Factor 2024: 1.5
5-Year Impact Factor: 2.2
Cite Score 2023: 3.6
SJR 2023: 0.573
SNIP 2022: 0.479
Open Access
Int J Mol Cell Med, Volume 11, No 4, Serial: 44 (Autumn 2022)
p-ISSN: 2251-9637 e-ISSN: 2251-9645
To cover the cost of publication, authors will pay an Article Processing Charge (APC) for accepted manuscripts from January 1, 2025.
Indexed in: Web of Sciences (ISI), PubMed, Scopus, Google Scholar, CAS, Index Copernicus, Index Medicus (IMEMR), ESJI, ISC, SID, Magiran, and Iranmedex
Impact Factor 2024: 1.5
5-Year Impact Factor: 2.2
Cite Score 2023: 3.6
SJR 2023: 0.573
SNIP 2022: 0.479
International Journal of Molecular and Cellular Medicine
Print ISSN: 2251-9637
Online ISSN: 2251-9645
Director-in-Charge:
Editor-in-Chief: Dr. Hadi Parsian
- Extracellular Signal-Regulated Kinase Inhibitor SCH772984 Augments the Anti-Cancer Effects of Gemcitabine in Nanoparticle Form in Pancreatic Cancer Models
Gauthami G Nair, Elena D Linster, Priyanka Ray, Mohiuddin A Quadir, Katie M Reindl - An In Silico Study of Transforming Growth Factor-β Inhibitors: A Potential Target for Diabetic Nephropathy Treatment with Active Compounds from the Active Fraction of Physalis angulata
Ika Rahayu, Nur Arfian, Kris Herawan Timotius, Mae Sri Hartati Wahyuningsih - Increased Expression of ITGB 3 in CLL Patient leukemia Cells by Exposure to Cold Physical Plasma and Plasma-treated Medium
Monireh Golpour, Farshad Sohbatzadeh, Mina Alimohammadi, Zahra Yazdani, Sadegh Fattahi, Ehsan Zaboli, Alireza Rafiei, Sander Bekeschus - Enhancement of the Sensitivity of the Acute Lymphoblastic Leukemia Cells to ABT-737 by Formononetin
Yusef Abbasi, Marziyeh Pooladi, Roya Nazmabadi, Jamal Amri, Helia Abbasi, Razieh Aghabeygi, Hadi Karami - Metformin as a Potential Therapeutic Agent in Breast Cancer: Targeting miR-125a Methylation and Epigenetic Regulation
Fatemeh Ahmadpour, Somayeh Igder, Alireza Eftekhari Moghadam, Bahman Moradipoodeh, Asma Sepahdar, Poneh Mokarram, Jafar Fallahi, Ghorban Mohammadzadeh - Lactobacillus Plantarum and its Derived Bacteriocin Exhibits Potent Antitumor Activity against Esophageal Cancer Cells
Salam Sabri, Saeed Esmaeili Mahani, Ahmed Majeed Al-Shammari, Khalid Jaber Kadhum luti, Mehdi Abbas Nejad - Biosynthesis of Copper Oxide-Silver Nanoparticles from Ephedra Intermedia Extract and Study of Anticancer Effects in HepG2 Cell Line: Apoptosis-Related Genes Analysis and Nitric Oxide Level Investigations
Nazanin Naderi, Azadeh Mohammadgholi, Nastaran Asghari Moghaddam - Circulating miRNA-106b-5p As a Potential Biomarker for Coronary Artery Disease
Rosita Azar Bahadori, Dina Shabani, Elham Arjmandrad, Mahsa Kazerani, Mina Rohani, Zohreh Ramazani Karim, Masoud Ali-Kheyl, Reza Nosratabadi, Hossein Pourghadamyari, Mohammad Ali Zaemi
- Year 2025
- Year 2024
- Year 2023
- Year 2022
- Year 2021
2010/07/1 - Indexing and Abstracting
Accepted Articles
Journal Information
- Current Issue: 2024، Volume 13، Number 3
- Print ISSN: 2251-9637
- Online ISSN: 2251-9645
- Director-in-Charge:
- Editor-in-Chief: Dr. Hadi Parsian
- Publisher: Babol University of Medical Sciences
Cost
To cover the cost of publication, authors will pay an Article Processing Charge (APC) for accepted manuscripts from January 1, 2025. Publication charge for authors whose papers are accepted to the journal is as follows:
| For Iranian Authors | For Overseas Authors | Article Type |
| 20,000,000 IRR | 600 USD | Review and original articles |
| 16,000,000 IRR | 500 USD | Short Communication and Case Series Articles |
| 10,000,000 IRR | 400 USD | Case Report articles |
| 5,000,000 IRR | 200 USD | Letter to Editor articles |
Note:
- The account number for Iranian authors is 2178455007004 of Melli Bank (Deposit ID no.9835000000280082) or shaba no. IR530170000002178455007004 and for overseas authors is: Account number-29401911, Swift code-Meliirthbbl, Branch code-9401.
- Authors are required to add the name of our journal in addition to the name of Babol University on their bank receipt.
- Please send a scanned copy of your receipt to the journal via info
ijmcmed.org - ./files/site1/files/Publication_fee_(1).pdf
Indexing Databases
Newsletter subscription
Enter your email address to have site news and announcements delivered directly to your inbox.
Site Statistics
- Registered users: 8189 users
- Online users: 2 users
- Guest users: 27 users
- All visits: 9999288 visits
- Visits in 24 Hours: 2483 visits
- Total articles: 2475 articles
- Published articles: 402 articles
Copyright Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
